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Huge advances have been made in cancer treatments over recent decades; however, 
significant disparities still exist in the developed world on the basis of race, 
socioeconomic status, education level, geographical location, and immigration status 
and in the USAnited States, insurance status. Cancer disparities persist in the 
continuum of cancer care from risk factors, screening, diagnosis, treatment, 
survivorship, and end-of-life care. The causes of disparities are complex and 
multifactorial. The MASCC (Multinational Association of Supportive Care in 
Cancer) Education Study Group would like to propose a framework of cancer 
disparities from a social perspective utilizing “social determinants of health” as 
delineated by the World Health Organization and highlight an unmet need for 
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Introduction 
Huge advances have been made in cancer treatments over recent decades; however, 
significant disparities still exist in the developed world on the basis of race, 
socioeconomic status, education level, geographical, location and immigration status 
and in the USAnited States, insurance status [1–6]. While there is no single 
definition to describe a developed country for the purpose of this article, we are 
including in developed world, countries with very high United Nations Human 
Development Index (HDI) [ 7]. HDI takes in to account transformation of income in 
educational and health opportunities and therefore in to higher level of human 
development. Cancer disparities continue to persist in the developed world 
through the continuum of cancer care from risk factors, screening, diagnosis, 
treatment, survivorship, and end-of-life care [8–10]. 
In the USA, African Americans experience higher rates of cancer overall and higher 
mortality from cancer [2]. Certain cancers have higher incidences in particular 
communities; for example, African Americans in the USAnited States suffer higher 
risk of prostate cancer and are more likely to die of this disease. Latina women in the 
USAnited States experience higher rates of cervical cancer. Similarly, Aborigines in 
Australia continue to experience higher rates of cancer deaths than non-iIndigenous 
populations; for example, cancer of trachea, bronchus, and lungs is 24.5 % higher in 
the Indigenous population [11]. Minorities in developed countries have poor access 
to health care, undergo cancer screening at much lower rates, and have higher 
mortality from cancer [12]. 
Cancer disparities: a complex challenge 
The causes of disparities are complex and multifactorial. They exist within and 
outside the medical systems in society. There are disparities in risk factors, economic 
and educational opportunities, and access to health care in different populations 
within a developed country [1, 5, 13]. There are significant differences within a 
country and significant differences between different countries in the developed 
world [4, 14, 15]. Ethnic minorities are over-represented within incarcerated 
populations [1, 16]. The economic and social disadvantages that underserved patients 
experience translates into worse cancer-related outcomes [17]. Underserved patients 
may have low health literacy, which is also associated with worse cancer outcomes 
[18]. 
Several ways exist to study cancer disparities. The MASCC (Multinational 
Association of Supportive Care in Cancer) Education Study Group would like to 
propose a framework of cancer disparities from a social perspective utilizing “social 
determinants of health” as delineated by World Health Organization. This model can 
be used to identify cancer disparities from risk factors, screening, diagnosis, 
treatment, and end-of-life care. These models represent variables that interact and 
modify each other. Individual factors such as age, sex, race, and biological 
characteristics are not modifiable; however, it is possible to mitigate negative 
experience associated with these characteristics. These characteristics form the 
individual and social basis of disparities. Older adults may suffer worse outcomes 
than younger patients by receiving a different treatment. Race/ethnicity is associated 
with negative experiences of discrimination and segregation of minorities. This may 
influence individual behaviors and risk factors from early childhood leading to 
disparities in the incidence and outcomes from cancer and other chronic diseases. 
Smoking rates are higher in racial and ethnic minorities and with lower education 
levels. Peer networks, parental smoking, and lack of support for ceasing smoking in 
immediate neighborhoods influence smoking rates. Minorities often live in poor 
neighborhoods with cramped living quarters, homelessness, and poor access to health 
care with few educational and economic opportunities. Lower education status has 
been associated with higher rates of smoking and higher rates of obesity. Recent 
migrants particularly from conflict areas of the world and undocumented migrants 
often live in poor neighborhoods and work in unregulated industries where they may 
be underpaid and experience unhealthy working conditions [19]. Minorities may 
have language discordance, different cultural beliefs than health care providers that 
may lead to dissatisfaction, and poor adherence with established care. Research 
studies tend to have smaller representation from minorities and underserved patients 
[9]. Treatment guidelines for cancer screening and treatment, which are based on 
these studies, may have limited application to underserved population. 
The social and economic impact of cancer disparities 
Disparities contribute to higher rates of cancer deaths in minorities. In the USAnited 
States, education attainment between lowest (<12 years) and highest education levels 
(>12 years) approximately doubles the risk of cancer mortality [ 2, 20]. Health-
related expenses increase the chances of descent into extreme poverty for already 
impoverished individuals. Minorities and vulnerable patients present at advanced 
stage of cancer with less chances of cure and higher risk of mortality [4]. Vulnerable 
patients are also less like to receive survivorship care, which decreases the chances 
of receiving appropriate care at time of recurrence and management of early and 
long-term effects of cancer and cancer treatments. This patient population is also less 
likely to receive end-of-life care increasing pain and suffering at the end of life [10]. 
The elimination of known risk factors and improving health can decrease the 
incidence of cancer. A higher uptake of screening can shift the cancer burden to an 
earlier stage resulting in more cures and lower disease burden. A higher access to 
pain medication and end of life can reduce pain and suffering associated with cancer 
(Fig. 1). 
Fig. 1 
Social framework for cancer disparities 
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Next steps 
Elimination of cancer disparities will require multilevel interventions. On an 
individual level, promoting health by influencing health behaviors and improving 
access to health information may be an important intervention. Harnessing different 
information resources such as culturally appropriate written materials, audio/video 
materials, and promoting individual health by increasing the awareness at a 
community level and by recruiting community leaders as part of an educational 
intervention may make such initiatives more effective or likely to succeed [21]. A 
peer support initiative where volunteer peer supporters are utilized to influence 
health behaviors may be more effective than fliers, books and handouts. Recognizing 
the strength of community may be useful, such as barbershop initiative for African 
American patients with hypertension [22]. 
At medical system levels, all clinicians and researches should be trained to recognize 
disparities and be aware of the biases that may hinder the patient-provider 
relationship and communication. Appropriate treatment should be available to all 
patients irrespective of their social or economic status. Medical researchers should 
identify not only causes of disparities but also test strategies to mitigate them. 
Inclusion of minorities in research studies should be prioritized as a requirement in 
research grants. Increasingly, in this global world, clinical trials that do not include 
the minorities may have limited applicability. This may require overcoming distrust, 
which minorities have with health systems, particularly with medical research. A 
concerted effort should be made to increase the number of minorities as care 
providers, researchers, and leaders in medical systems. This will enrich our 
organizations with diversity of experiences and perspectives. While health policies 
can be a significant intervention to reduce health care disparities, it is social and 
economic policy that can have the most far-reaching consequences on reducing 
disparities. The lessons learned in testing these interventions can lead to significant 
reductions in cancer deaths in developed countries and can be applied to the 
developing world. 
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